Clinical Trials in Denver

Showing 12401-12420 of 15,604 trials

Beryllium Infliximab Study: Clinical Interventional Trial

NCT00111917

The goal of this research study is to test the clinical effectiveness of a drug called infliximab (Remicade) in chronic beryllium disease (CBD). This drug may reduce tumor necrosis factor-alpha (TNF-a), which is associated with more severe disease and inflammation in the lung. Receiving infliximab may help with symptoms, and may improve clinical testing data normally ordered by your doctor, such as breathing tests. Baseline and follow-up testing will look for improvements in breathing tests (pulmonary function testing), exchange of oxygen in the lungs (exercise test), chest x ray, and lung inflammation.

BerylliosisBeryllium Disease

Maier, Lisa, M.D.13 participantsStarted Feb 2005

Denver, Colorado, United States

COMPLETED< 1 mile

An Observational Study of OZURDEX® in Diabetic Macular Edema (DME)

NCT02188173

This is a study of OZURDEX® use in clinical practice in patients with diabetic macular edema (DME).

Macular Edema

Allergan200 participantsStarted Jul 2014

Phoenix, Arizona, United States • San Francisco, California, United States • Santa Ana, California, United States +15 more locations

Beryllium Infliximab Study: Clinical Interventional Trial

An Observational Study of OZURDEX® in Diabetic Macular Edema (DME)

Find Trials by Condition in Denver

Comparison of TAK-875 to Placebo as an Add-on to Glimepiride in Patients With Type 2 Diabetes

Study of Intravitreal Aflibercept Injection (IAI; EYLEA®; BAY86-5321) in Patients With Diabetic Macular Edema

Vistakon Investigational Contact Lenses Worn for Daily Wear

Dose Ranging Study of Celivarone With Amiodarone as Calibrator for the Prevention of Implantable Cardioverter Defibrillator (ICD) Interventions or Death

Study of HUCNS-SC Subretinal Transplantation in Subjects With GA of AMD

Comparison of Fasiglifam (TAK-875) to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes

TAK-875 (Fasiglifam) in Combination With Sitagliptin in Adults With Type 2 Diabetes

Risedronate to Prevent Skeletal Related Events in Patients With Metastatic Prostate Cancer Commencing Hormonal Therapy

A Study to Evaluate ITCA 650 Compared to Sitagliptin as add-on Therapy for the Treatment of Type 2 Diabetes

Evaluation of the Pharmacokinetics, Safety, and Tolerability of TPM XR as Adjunctive Therapy in Pediatric Subjects With Epilepsy

A Study to Evaluate the Efficacy and Safety of Ibrutinib, in Patients With Mantle Cell Lymphoma Who Progress After Bortezomib Therapy

A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis

Randomized Trial of Fulvestrant With or Without Dasatinib in Men and Postmenopausal Women Who Have Hormone Receptor-positive Advanced Breast Cancer Previously Treated With an Aromatase Inhibitor

Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Carcinoma

A Study of Effectiveness and Safety of JNJ-42160443 in Patients With Diabetic Painful Neuropathy

Safety and Efficacy Study in Acute Ischaemic Stroke

Study Comparing Daclatasvir (BMS-790052) With Telaprevir Combined With Peginterferon Alfa-2a and Ribavirin in Patients With Chronic Hepatitis C Virus Infection

Larotaxel Compared To Continuous Administration of 5-FU in Advanced Pancreatic Cancer Patients Previously Treated With A Gemcitabine-Containing Regimen